ALVA MOY-DALEY: Open Payments
NPI 1073944104 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 48 payments from 21 companies in 2025. Trend: 2023 $470 · 2024 $1,480 · 2025 $837
Food & beverage: $821Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $186 |
| Lilly USA, LLC | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Dexcom, Inc. | 3 | $65 |
| Abbott Laboratories | 2 | $48 |
| Corcept Therapeutics | 2 | $33 |
| Insulet Corporation | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Radius Health, Inc. | 1 | $22 |
Products named: Rybelsus, Kerendia, Ozempic, Dexcom G6 Transmitter, JARDIANCE, MOUNJARO, FREESTYLE LIBRE, Wegovy.
Industry payments across NJ — which companies pay providers there.
